Ipca Laboratories Ltd

Ipca Laboratories Ltd | Sector: Pharmaceuticals | ISIN: INE571A01038

₹ 782.90 (-0.19%) icon

24 Mar, 2023, 12:33:56 PM
Open
₹ 781.10
Prev. Close
₹ 784.40
Turnover(lac)
₹ 175.90
Day's High
₹ 788.50
Day's Low
₹ 781.10
52 Wk High
₹ 1,095.00
52 Wk Low
₹ 767.50
Book Value
₹ 234.73
Face Value
₹ 1.00
Mkt. Cap (Cr.)
₹ 19,862.50
P/E
36.73
EPS
21.37
Div. Yield
0.51

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/24/2023 12:33:56 PM

    ₹ 782.9 -1.50 -0.19
  • Open
  • ₹ 781.1
  • Prev. Close
  • ₹ 784.4
  • Turnover(Lac.)
  • ₹ 176
  • Day's High
  • ₹ 788.5
  • Day's Low
  • ₹ 781.1
  • 52 Week's High
  • ₹ 1,095
  • 52 Week's Low
  • ₹ 767.5
  • Book Value
  • ₹ 234.73
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 19,862.5
  • P/E
  • 36.73
  • EPS
  • 21.37
  • Divi. Yield
  • 0.51

Corporate Actions

20 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 Jan , 2023

12:00 AM

11 Nov , 2022

12:00 AM

Dividend

Dividend amount: 4
Announcement date: 11 Nov , 2022

View Details

02 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Nov , 2022

12:00 AM

20 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Jul , 2022

12:00 AM

AGM

Announcement date: 14 Jul , 2022

View Details

28 Jul , 2022

12:00 AM

12 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Jul , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
24 March , 2023 | 12:34 PM

PROMOTER - TOTAL46.29%

Indian: 46.29%

Foreign: 0%

NON-PROMOTER - TOTAL 53.71%

Institutions: 44.49%

Non-Institutions: 9.22%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Ipca Laboratories Ltd News and Update

Image not found
  • 5 hours ago |
  • 4:03 PM

According to a BSE filing, the parties to the proposed transaction, for which a legally binding memorandum of understanding had previously been signed, had "executed a Share Purchase Agreement and finalized the transaction."

Article Image
  • IIFL News Service |
  • 1 day ago |
  • 4:02 PM
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Ipca Laboratories Ltd

  • Premchand Godha

  • Chairman & MD & CEO
  • A K Jain

  • Joint Managing Director & CFO
  • Anand T Kusre

  • Independent Director
  • Pranay Godha

  • Executive Director
  • Harish P Kamath

  • Company Secretary
  • Prashant Godha

  • Executive Director
  • Manisha Premnath

  • Independent Director
  • Kamal Kishore Seth

  • Independent Director
  • Narendra Mairpady

  • Additional Director

Summary

Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of The Indian Pharmaceutical Combine Association Limited. Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 APIs covering various therapeutic segments. The products of the Company are now sold in over 100 countries across the globe. The Company has 17 manufacturing units in India manufacturing APIs and formulations for the world market.Ipcas APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries. Ipca is one of the biggest manufacturers in the world of APIs Atenolol (Antihypertensive), Chloroquine Phosphate (Antimalarial), Furosemide (Diuretic) and Pyrantel Salts (Anthelmintic) right from the basic stage. Ipca is also one of the largest suppliers of these APIs and their intermediates world over. The name of the company was changed to Ipca Laboratories Limited in 6th August of the year 1964 and again name was changed to Ipca Laboratories Private Limited in 13th January of the year 1966. Ipca had commissioned one of the first modern Pharma factory of yesteryears... Read More


Reports by Ipca Laboratories Ltd


Reports by Ipca Laboratories Ltd